← Scroll for more →
Regeneron Pharmaceuticals, Inc. (REGN)
Pharmaceutical Preparations
Latest Price
$927.89
TTM P/E
20.52
Normalized P/E
22.11
TTM Div Yield
0.30%
Fwd Div Yield
0.41%
Book Value
329.39
P/B Ratio
2.82
Valuation metrics
adjust assumptions →EPS: $41.48
Book value / share: $287.82
Formula: √(22.5 × EPS × BVPS)
Graham Number
$518.29
36% downside
Norm. op. income: $4.0B (median of 7yr)
Tax rate: 11%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$389.06
52% downside
Base FCF: $4.1B (median of recent 5yr)
Growth: -3%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$428.04
47% downside
EPS: $41.48
Target P/E: 20×
Formula: EPS × P/E
P/E Fair Value
$829.60
+2% upside
Institutional Ownership
89.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.11M | $5.68B | 8.81% | +165.8K | 2026-06-30 |
| Vanguard Capital Management LLC | 6.63M | $4.13B | 6.41% | -25.2K | 2026-06-30 |
| Dodge & Cox | 4.87M | $3.04B | 4.71% | +412.9K | 2026-06-30 |
| State Street Corp | 4.83M | $3.01B | 4.68% | +170.2K | 2026-06-30 |
| Invesco Ltd. | 3.94M | $2.46B | 3.81% | +2.22M | 2026-06-30 |
| JPMorgan Chase & Co | 3.77M | $2.38B | 3.65% | -166.0K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 3.18M | $1.98B | 3.07% | +1.45M | 2026-06-30 |
| Franklin Resources Inc | 2.77M | $1.73B | 2.68% | +49.8K | 2026-06-30 |
| Geode Capital Management, LLC | 2.63M | $1.63B | 2.54% | +18.1K | 2026-06-30 |
| Nuveen, LLC | 2.02M | $1.26B | 1.95% | -45.1K | 2026-06-30 |